Preparation method and application of ginsenoside composition

文档序号:1053482 发布日期:2020-10-13 浏览:34次 中文

阅读说明:本技术 一种人参皂苷组合物的制备方法及其应用 (Preparation method and application of ginsenoside composition ) 是由 李俊 章漳 蒋耀权 于 2019-04-01 设计创作,主要内容包括:本发明公开了一种人参皂苷组合物的制备方法。所述的制备方法包括使用巴斯德毕赤酵母CCTCC NO.M 2016763对人参全株提取物进行发酵,即得。本发明的巴斯德毕赤酵母经特定生物发酵转化工艺后,相比人参全株提取物底物,发酵滤液中Rd、CK和R-Rg<Sub>3</Sub>的提升幅度分别可高达9%、37%和2400%,为本领域稀有皂苷的制备提供了新的方向和思路;此外本发明获得的人参皂苷组合物对角质细胞的修复能力更强。(The invention discloses a preparation method of a ginsenoside composition. The preparation method comprises fermenting the whole plant extract of Ginseng radix with Pichia pastoris CCTCC NO. M2016763. After the Pichia pastoris is subjected to a specific biological fermentation and conversion process, compared with a substrate of a whole ginseng plant extract, Rd, CK and R-Rg in fermentation filtrate 3 The promotion range of the saponin can reach 9 percent, 37 percent and 2400 percent respectively, and a new direction is provided for the preparation of rare saponin in the fieldAnd the idea; in addition, the ginsenoside composition obtained by the invention has stronger repairing capability on keratinocytes.)

1. A method for preparing ginsenoside composition comprises fermenting whole plant extract of radix Ginseng with Pichia pastoris CCTCCNO.M 2016763.

2. The method of claim 1, comprising the steps of:

(1) inoculating 0.5-5 v/v% of the seed solution of the Pichia pastoris CCTCC NO. M2016763 into 0.2-5 wt% of the ginseng whole plant extract solution;

(2) fermenting and converting at 25-35 ℃.

3. The method according to claim 2, wherein the 0.2-5 wt% ginseng whole plant extract solution in step (1) is obtained by dissolving a ginseng whole plant extract lyophilized powder in deionized water;

preferably, the inoculation volume of the seed solution is 1 v/v%, and the concentration of the ginseng whole plant extract freeze-dried powder in the ginseng whole plant extract solution is 1 wt%.

4. The method of claim 3, wherein the lyophilized powder of whole ginseng extract is 1% lyophilized powder of whole ginseng extract;

the preparation of the 1% ginseng whole plant extract freeze-dried powder preferably comprises the following steps: crushing a ginseng sample, dissolving the crushed ginseng sample in water, heating in water bath, filtering to obtain filtrate, carrying out rotary evaporation and concentration on the filtrate, and drying in vacuum to obtain the ginseng extract; the mass volume percentage of the ginseng sample and the water is 1%, and the unit of the mass volume percentage is g/mL; in the ginseng sample, the mass ratio of roots, stems, leaves, flowers and seeds is (80-95): 1-10): 0.5-5, preferably 90:5:2.5: 2.5;

the temperature of the water bath heating is preferably 92-98 ℃, and more preferably 96 ℃;

the time of the water bath heating is preferably 1.5 to 2.5 hours, and more preferably 2.0 hours.

5. The method according to claim 4, wherein the filtrate is frozen at-20 ℃ for 48 hours after filtration.

6. The method of claim 2, wherein the seed liquid in step (1) is obtained by:

a. inoculating pichia pastoris CCTCC NO.M 2016763 into a potato glucose culture medium, and carrying out shake culture for 16-18 h to obtain a primary seed solution;

b. inoculating the primary seed liquid obtained in the step a to a potato glucose culture medium according to the inoculation amount of 5 v/v%, and performing shake culture for 16-18 h to obtain a seed liquid;

the speed of the shaking culture is preferably 200 rpm.

7. The method of claim 2, wherein the temperature of the fermentative conversion in step (2) is 30 ℃;

and/or the rotation speed of the fermentation conversion in the step (2) is 150-250 rpm, preferably 200 rpm;

and/or, the fermentation conversion in the step (2) is carried out in a gas-filled state; the gas is preferably sterile air, and the speed of the introduced gas is 1000 to 3000ccm, preferably 2000 ccm.

8. A ginsenoside composition prepared according to any one of the preparation methods of claims 1-7.

9. A ginsenoside composition of claim 8, in the preparation of a human keratinocyte repair agent, preferably in the form of a skin care product or a cosmetic product.

10. Application of Pichia pastoris CCTCC NO. M2016763 in preparing ginsenoside composition is provided;

the ginsenoside is preferably rare ginsenoside.

Technical Field

The invention belongs to the field of bioengineering, and relates to a preparation method and application of a ginsenoside composition.

Background

Ginseng (Panax ginseng C.A. Mey.) is a perennial herb of Panax of Araliaceae,originally recorded in Shen nong Ben Cao Jing (Shen nong's herbal), it has the actions of invigorating primordial qi, restoring pulse, relieving depletion, invigorating spleen and lung, etc., and is a common tonic, and its main active ingredient is ginsenoside. Ginsenoside is a steroid compound, and there are many monomer types in ginseng, which is a triterpenoid compound formed by connecting sugar chains and aglycons. Ginsenoside can affect multiple metabolic pathways, and some rare human saponins can obviously prevent cancer and inhibit tumor and cancer cells, and can be applied to the fields of anticancer clinical treatment and cancer drug development. Ginsenoside Rb in Ginseng radix1Rd, Re, etc. are higher, while Rg1、Rg3、Rh1、Rh2The ginsenoside is rare, has higher activity, and has unique effects in improving memory and preventing and treating tumor. When the saponin is absorbed by a human body, the saponin is degraded and deglycosylated, and the diol type saponin is decomposed into CK and enters blood; the triol type requires hydrolysis to protopanaxatriol (Ppt) to enter the blood. Although the ginseng contains abundant natural ginsenoside, the ginseng is poorly absorbed in human intestines and stomach, and the content of saponin metabolites CK and Ppt and the like with real pharmacological efficacy is very low, so that the blood concentration in a human body after eating the ginseng is difficult to reach the concentration which can fully exert the pharmacological activity. The key and difficult points of the intensive research are to find a feasible extraction method or a process path for producing high-value rare ginsenoside monomers, and the mass preparation of secondary saponin and aglycone has extremely high medicinal value and commercial value.

The method for fermenting ginseng roots, flowers, seeds and the like by using microorganisms as substrates is a deep research which is carried out by combining a biotransformation technology and a fermentation technology and has important practical exploration value in order to solve the practical problems of few types, low content, high extraction difficulty and the like of rare ginsenoside on the basis of knowing the efficacy characteristics of ginseng active ingredients. The principle is that one or more enzymes generated in the microbial metabolism process are used for structurally modifying sugar chains on C-3, C-6 and C-20 positions of ginsenoside, and the glycosidic bond is hydrolyzed through enzyme catalytic reaction, so that the main ginsenoside in ginseng is directionally converted into rare ginsenoside or decomposed into aglycone, and the types and the amount of functional components directly taken by a human body in the ginseng fermented extract are obviously improved. In addition, compared with the direct extraction of plant components, the fermentation technology can ensure that the hyphae grow, reproduce and metabolize vigorously through proper temperature, pH, oxygen and nutrient components, and obtain a large amount of hyphae or secondary metabolites.

The cracking and transformation of the ginsenoside is carried out by beneficial microorganisms (probiotic bacteria) and glucose lyase metabolized by the beneficial microorganisms, and the ginsenoside can be more efficiently absorbed by a human body. Lactic acid bacteria and bacillus are the most common strains in ginseng fermentation research, however, compared with a pichia pastoris eukaryotic expression system, and fermentation periods (such as 16d) of prokaryotic bacteria such as lactic acid bacteria and bacillus, the pichia pastoris has translated processing modified enzyme proteins such as glycosylation, protein phosphorylation and fat acylation, the expressed target saponin invertase activity and yield are high, the saponin invertase fermentation period can be shortened, and the yield of target rare saponin can be increased. Even though some of the descriptions about the preparation of ginsenosides by using pichia pastoris exist, the substrates mainly comprise glucose or ginsenoside precursors and the like, and the ginsenosides precursors are synthesized by a dammarenediol metabolic pathway, so that the yield and the conversion rate are low.

Therefore, there is still a need to further increase the metabolic pathway of the triterpene synthesis pathway of pichia pastoris through metabolic engineering or process engineering technology, so as to further improve the production efficiency and yield of rare saponins.

Disclosure of Invention

The invention aims to solve the technical problem of overcoming the defect of low yield of rare ginsenoside produced by using pichia pastoris in the prior art, and provides a preparation method and application of a ginsenoside composition.

The invention creatively uses Pichia pastoris CCTCC NO. M2016763 to biodegrade the high molecular weight ginsenoside in the whole ginseng plant extract into the low molecular weight ginsenoside (such as Rd, CK, Rg) for the first time through a biological fermentation and transformation process2And Rg3Etc.) and specifically transformed to obtain a higher proportion of rare ginsenosides. On one hand, the metabolite in the yeast growth and metabolism process is utilized, and on the other hand, the yeast biotransformation is utilized to extract the whole ginsengThe rare ginsenoside in the extract can make the fermentation product filtrate have good skin care effects in resisting aging and repairing cells.

The invention provides a preparation method of a ginsenoside composition, which comprises the step of fermenting a whole ginseng plant extract by using pichia pastoris CCTCCNO.M 2016763.

The preparation method preferably comprises the following steps:

(1) inoculating 0.5-5 v/v% of the seed solution of the Pichia pastoris CCTCC NO. M2016763 into 0.2-5 wt% of the ginseng whole plant extract solution;

(2) fermenting and converting at 25-35 ℃.

Wherein, the solvent in the 0.2-5 wt% ginseng whole plant extract solution in the step (1) can be conventional in the art, such as water; preferably, the 0.2-5 wt% ginseng whole plant extract solution is obtained by dissolving ginseng whole plant extract freeze-dried powder in deionized water (i.e. the solution obtained by mixing the ginseng whole plant extract freeze-dried powder with the water, and the ginseng whole plant extract freeze-dried powder accounts for 0.2-5% of the total weight of the ginseng whole plant extract freeze-dried powder and the ionized water).

Preferably, the inoculation volume of the seed solution is 1 v/v%, and the concentration of the ginseng whole plant extract freeze-dried powder in the ginseng whole plant extract solution is 1 wt%.

The ginseng whole plant extract freeze-dried powder can be the ginseng whole plant extract freeze-dried powder which is conventional in the field, and 1% of ginseng whole plant extract freeze-dried powder is preferred.

The preparation method of the 1% ginseng whole plant extract freeze-dried powder can be conventional in the field. Preferably, the preparation method comprises the following steps: crushing a ginseng sample, dissolving the crushed ginseng sample in water, heating in water bath, filtering to obtain filtrate, carrying out rotary evaporation and concentration on the filtrate, and drying in vacuum to obtain the ginseng extract; the mass volume percentage of the ginseng sample and the water is 1%, and the unit of the mass volume percentage is g/mL; in the ginseng sample, the mass ratio of roots, stems, leaves, flowers and seeds is (80-95): 1-10): 0.5-5, preferably 90:5:2.5: 2.5. The temperature of the water bath heating is preferably 92-98 ℃, more preferably 96 ℃. The time of the water bath heating is preferably 1.5 to 2.5 hours, and more preferably 2.0 hours.

In order to ensure the activity of the ginseng whole plant extract solution, avoid pollution and facilitate subsequent freeze vacuum drying, the filtrate is frozen and stored for 48 hours at the temperature of minus 20 ℃ after the filtrate is obtained by filtration.

The seed solution in the step (1) can be prepared by conventional methods in the field, and is preferably obtained by the following steps:

a. inoculating pichia pastoris CCTCC NO.M 2016763 into a potato glucose culture medium, and carrying out shake culture for 16-18 h to obtain a primary seed solution;

b. inoculating the primary seed liquid obtained in the step a to a potato glucose culture medium according to the inoculation amount of 5 v/v%, and performing shake culture for 16-18 h to obtain a seed liquid;

the speed of the above shaking culture is preferably 200 rpm.

In the step (2) of the above production method, the temperature of the fermentative conversion is preferably 30 ℃.

The rotation speed of the fermentation conversion in the step (2) is preferably 150 to 250rpm, more preferably 200 rpm.

In order to ensure the oxygen requirement in the normal growth and metabolism process of the thalli, the fermentation conversion in the step (2) is preferably carried out in a gas-filled state; the gas is preferably sterile air, and the speed of the introduced gas is preferably 1000 to 3000ccm, and more preferably 2000 ccm.

The invention provides a ginsenoside composition prepared according to the preparation method.

The invention provides an application of the ginsenoside composition in preparing a human keratinocyte repairing agent, wherein the human keratinocyte repairing agent is preferably in the form of skin care products or cosmetics.

The invention provides an application of pichia pastoris CCTCC NO.M 2016763 in preparing a ginsenoside composition or a human keratinocyte repairing agent;

the ginsenoside composition is preferably rare ginsenoside, such as Rd, CK, Rg2AndRg3

the human keratinocyte restoration agent is preferably in the form of a skin care product or a cosmetic product.

On the basis of the common knowledge in the field, the above preferred conditions can be combined randomly to obtain the preferred embodiments of the invention.

The reagents and starting materials used in the present invention are commercially available.

The positive progress effects of the invention are as follows:

after the pichia pastoris is subjected to a biological fermentation conversion process, compared with a substrate of a whole ginseng plant extract, Rd, CK and R-Rg in fermentation filtrate3The promotion range of the rare saponins can reach 9 percent, 37 percent and 2400 percent respectively, and a new direction and thought are provided for the preparation of the rare saponins in the field; in addition, the ginsenoside composition prepared by the invention has strong capability of repairing keratinocytes.

Biological material preservation information

The space yeast JBA-SP02-DZ-08-Gly-01 is preserved in China Center for Type Culture Collection (CCTCC) at 18 months 12 in 2016, and the preservation address is as follows: wuhan university collection center in Wuchang district, Wuhan city, Hubei province, zip code: 430072, with the preservation number: m2016763, culture name JBA-SP02-DZ-08-Gly-01, and classification name Pichia pastoris (Pichia pastoris).

Drawings

FIGS. 1A-C show HPLC chromatogram before and after fermentation of second generation space yeast fermentation liquid.

FIG. 2 shows scratch repair effects of different final concentrations of fermentation broth before and after fermentation.

Detailed Description

The invention is further illustrated by the following examples, which are not intended to limit the scope of the invention. The experimental methods without specifying specific conditions in the following examples were selected according to the conventional methods and conditions, or according to the commercial instructions.

11页详细技术资料下载
上一篇:一种医用注射器针头装配设备
下一篇:一种应用天然免疫激活剂抗病毒的方法

网友询问留言

已有0条留言

还没有人留言评论。精彩留言会获得点赞!

精彩留言,会给你点赞!